perphenazine has been researched along with ergotamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glennon, RA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Nasr, H; Pearson, OH | 1 |
Rolinski, Z; Scheel-Krüger, J | 1 |
Jonas, W; Scheel-Krüger, J | 1 |
1 review(s) available for perphenazine and ergotamine
Article | Year |
---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
7 other study(ies) available for perphenazine and ergotamine
Article | Year |
---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of prolactin secretion by ergot alkaloids.
Topics: Animals; Depression, Chemical; Dihydroergotamine; Dihydroergotoxine; Ergolines; Ergot Alkaloids; Ergotamine; Estradiol; Estrus; Female; Mammary Neoplasms, Experimental; Perphenazine; Pituitary Gland; Pregnancy; Prolactin; Rats | 1975 |
The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
Topics: Adrenergic alpha-Antagonists; Amphetamine; Animals; Aza Compounds; Behavior, Animal; Depression, Chemical; Dopamine Antagonists; Dopamine beta-Hydroxylase; Ergotamine; Female; Haloperidol; Male; Methyltyrosines; Mice; Motor Activity; Norepinephrine; Perphenazine; Phenoxybenzamine; Phenyl Ethers; Pimozide; Piperidines; Rats; Receptors, Drug; Spiro Compounds; Time Factors; Tranquilizing Agents; Trifluoperazine | 1973 |
Pharmacological studies on tetrabenazine-induced excited behaviour of rats pretreated with amphetamine or nialamide.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Drug Synergism; Ergotamine; Germ-Free Life; Haloperidol; Humans; Locomotion; Male; Methyltyrosines; Mice; Nialamide; Norepinephrine; Perphenazine; Phenoxybenzamine; Receptors, Cholinergic; Reserpine; Scopolamine; Stereotyped Behavior; Tetrabenazine | 1973 |